Study Links a Common Bone Medicine to a Lower Dementia Risk

Research reported this month suggests that a common group of bone medicines may be tied to a lower risk of dementia in older adults. ScienceDaily shared the findings on November 9, drawing on a study by researchers at the University of Hong Kong. The study itself was published in 2025 in a medical journal, and the recent coverage brought it wider attention.

The team looked at health records for more than 120,000 people age 60 and older who had osteoporosis or had suffered a fragility fracture, the kind of broken bone that happens from a minor fall or even normal activity when bones are weak.

The researchers focused on a widely used class of drugs called nitrogen containing bisphosphonates. Two common ones are alendronate and zoledronate. People who took these drugs had a 16 percent lower chance of being diagnosed with dementia than people who took no osteoporosis medicine at all. Compared with patients taking other kinds of osteoporosis drugs, the bisphosphonate users had a 24 percent lower risk.

The link looked strongest in women and in people who had broken a hip. The researchers estimated that treating 48 patients with these drugs over five years might prevent one case of dementia, based on the patterns they saw in the records.

The scientists were careful about what the findings do and do not show. The study does not prove that the drugs themselves stop dementia. It shows an association, which means the two things tend to appear together, not that one causes the other. The researchers said more study is needed before anyone can say these drugs directly prevent or delay Alzheimer's disease and related forms of dementia.

For readers 50 and older, the practical takeaway is simple. This is early research, not a reason to start or stop any medicine on your own. Millions of older adults, especially women after menopause, already take bisphosphonates to protect their bones and lower the chance of a serious fracture. If you have questions about whether one of these drugs is right for you, the best step is to talk with your own doctor, who knows your history and can weigh the benefits against the risks.